Veterinary Practice News • Veterinary Practice News Canada • VetMedTeam • VetCE • Veterinary Professionals' NextGen

ACCOUNT SETTINGS
LOG OUT

Sign up for our weekly newsletter

News
Practice Management
Cat/Dog
Medicine
Brain Teaser
Education
MORE

Equine/Large Animal
Avian/Exotic
Videos
Get the Magazine
Classifieds
Products
- Demo-Casts
- Product Profiles
Events
Archives
- Digital Editions
- Newsletters
Digital Editions
Newsletters
E-book

#KIND-030

Parvo preventative picks up speed

December 29, 2020

Elanco Animal Health is set to acquire the global rights to Kindred Biosciences’ proprietary KIND-030, a monoclonal antibody being developed for the treatment and prevention of canine parvovirus.

SPONSORED CONTENT

The Next Breakthrough in Feline OA Pain Management

New on

Join VPN Plus+ today to get access to exclusive content like:

Compassion without the fatigue

Video: Tips to working with clients who have mental health conditions

We finally learn…what’s in the box!

A new way to go green: mentor a recent graduate

COVID-19

Living with PTSD in a post-COVID world

Parvo cases jump a whopping 70 percent during COVID

Making technology work while in coronavirus mode (and beyond)

Stay alert of possible ivermectin misuse amid pandemic, FDA warns

Dogs stressed, fearful when without owners during exams

Load More

About Us
About VPN Plus+
Contact Us
Advertise

Get the Magazine
Get our Newsletter

Privacy Policy
Terms of Use

FOLLOW US @VetPracticeNews
#VetPracticeNews

Copyright ©2021 Kenilworth Media Inc. All Rights Reserved.